Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Aug;100(4):850–854. doi: 10.1111/j.1476-5381.1990.tb14103.x

Effect of 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline (CNQX) on dorsal root-, NMDA-, kainate- and quisqualate-mediated depolarization of rat motoneurones in vitro.

S K Long 1, D A Smith 1, R J Siarey 1, R H Evans 1
PMCID: PMC1917604  PMID: 1976402

Abstract

1. Mature in vitro rat spinal cord preparations have been used to compare the depressant effects of 6-cyano-2,3-dihydroxy-7-nitroquinoxalinedione (CNQX) and kynurenate on transmission from low threshold myelinated primary afferents in dorsal roots. EC50 values +/- s.e.mean (number of preparations in parentheses) for depression of the monosynaptic ventral root reflex were respectively 1.0 +/- 0.3 microM (5) and 135 +/- 15 microM (3) for CNQX and kynurenate. Transmission through superior cervical ganglia was not significantly affected by concentrations of CNQX up to 100 microM or kynurenate up to 5 mM. 2. Immature in vitro rat spinal cord preparations were used to measure dose-ratios for antagonism of depolarizations induced by N-methyl-D-aspartate (NMDA), kainate or quisqualate by 4, 10 and 25 microM CNQX. In the presence of 0.75 mM Mg2+ pA2 values +/- s.e.mean were respectively 4.62 +/- 0.05 (16), 5.79 +/- 0.01 (4) and 5.59 +/- 0.05 (16) for each agonist. These values were not significantly altered in the absence of added Mg2+. The mean pA2 values for kainate were significantly higher than those for quisqualate (P less than 0.01). 3. Antagonism of NMDA-induced depolarizations was evident at 10 and 25 but not 4 microM CNQX. The antagonism of NMDA was reversed by D-serine (100 and 200 microM). 4. A similarity between the relative potencies of both CNQX and kynurenate for depression of synaptic transmission and antagonism of amino acid-induced depolarizations indicates that monosynaptic transmission from myelinated primary afferents to motoneurones is mediated by kainate and/or quisqualate sub-types of non-NMDA receptors.

Full text

PDF
850

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bashir Z. I., Tam B., Collingridge G. L. Activation of the glycine site in the NMDA receptor is necessary for the induction of LTP. Neurosci Lett. 1990 Jan 22;108(3):261–266. doi: 10.1016/0304-3940(90)90651-o. [DOI] [PubMed] [Google Scholar]
  2. Birch P. J., Grossman C. J., Hayes A. G. 6,7-Dinitro-quinoxaline-2,3-dion and 6-nitro,7-cyano-quinoxaline-2,3-dion antagonise responses to NMDA in the rat spinal cord via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol. 1988 Oct 26;156(1):177–180. doi: 10.1016/0014-2999(88)90163-x. [DOI] [PubMed] [Google Scholar]
  3. Blake J. F., Brown M. W., Collingridge G. L. CNQX blocks acidic amino acid induced depolarizations and synaptic components mediated by non-NMDA receptors in rat hippocampal slices. Neurosci Lett. 1988 Jun 29;89(2):182–186. doi: 10.1016/0304-3940(88)90378-3. [DOI] [PubMed] [Google Scholar]
  4. Blake J. F., Yates R. G., Brown M. W., Collingridge G. L. 6-Cyano-7-nitroquinoxaline-2,3-dione as an excitatory amino acid antagonist in area CA1 of rat hippocampus. Br J Pharmacol. 1989 May;97(1):71–76. doi: 10.1111/j.1476-5381.1989.tb11925.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Childs A. M., Evans R. H., Watkins J. C. The pharmacological selectivity of three NMDA antagonists. Eur J Pharmacol. 1988 Jan 5;145(1):81–86. doi: 10.1016/0014-2999(88)90352-4. [DOI] [PubMed] [Google Scholar]
  6. Evans R. H., Evans S. J., Pook P. C., Sunter D. C. A comparison of excitatory amino acid antagonists acting at primary afferent C fibres and motoneurones of the isolated spinal cord of the rat. Br J Pharmacol. 1987 Jul;91(3):531–537. doi: 10.1111/j.1476-5381.1987.tb11246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Evans R. H., Francis A. A., Jones A. W., Smith D. A., Watkins J. C. The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations. Br J Pharmacol. 1982 Jan;75(1):65–75. doi: 10.1111/j.1476-5381.1982.tb08758.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fletcher E. J., Martin D., Aram J. A., Lodge D., Honoré T. Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro. Br J Pharmacol. 1988 Oct;95(2):585–597. doi: 10.1111/j.1476-5381.1988.tb11680.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Foster A. C. Neurobiology. Quisqualate receptor antagonists. Nature. 1988 Oct 20;335(6192):669–670. doi: 10.1038/335669a0. [DOI] [PubMed] [Google Scholar]
  10. Ganong A. H., Lanthorn T. H., Cotman C. W. Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res. 1983 Aug 22;273(1):170–174. doi: 10.1016/0006-8993(83)91108-3. [DOI] [PubMed] [Google Scholar]
  11. Honoré T., Davies S. N., Drejer J., Fletcher E. J., Jacobsen P., Lodge D., Nielsen F. E. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science. 1988 Aug 5;241(4866):701–703. doi: 10.1126/science.2899909. [DOI] [PubMed] [Google Scholar]
  12. Jahr C. E., Yoshioka K. Ia afferent excitation of motoneurones in the in vitro new-born rat spinal cord is selectively antagonized by kynurenate. J Physiol. 1986 Jan;370:515–530. doi: 10.1113/jphysiol.1986.sp015948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Johnson J. W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987 Feb 5;325(6104):529–531. doi: 10.1038/325529a0. [DOI] [PubMed] [Google Scholar]
  14. Kemp J. A., Foster A. C., Leeson P. D., Priestley T., Tridgett R., Iversen L. L., Woodruff G. N. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6547–6550. doi: 10.1073/pnas.85.17.6547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Long S. K., Evans R. H., Cull L., Krijzer F., Bevan P. An in vitro mature spinal cord preparation from the rat. Neuropharmacology. 1988 May;27(5):541–546. doi: 10.1016/0028-3908(88)90138-4. [DOI] [PubMed] [Google Scholar]
  16. Monaghan D. T., Olverman H. J., Nguyen L., Watkins J. C., Cotman C. W. Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9836–9840. doi: 10.1073/pnas.85.24.9836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Thomson A. M., Walker V. E., Flynn D. M. Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices. Nature. 1989 Mar 30;338(6214):422–424. doi: 10.1038/338422a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES